Remove Clinical Research Remove Clinical Supply Remove Therapies
article thumbnail

How to Optimize Drug Development by Combining FSO and FSP Models

PPD

Approaches to outsourcing clinical trials have changed significantly in recent years. Mixing of service models — a strategy that drug developers are leveraging now more than ever — can bring life-changing therapies to market faster. Most often done using the vendor’s systems and standard operating procedures (SOP).

article thumbnail

Molecular Partners Announces Collaboration With Novartis to Develop Two DARPin(R) Therapies Designed for Potential Use Against COVID-19

The Pharma Data

During the clinical development stage, Molecular Partners will provide clinical supply. The companies will work together to scale-up manufacturing capacity, in collaboration with Sandoz, the generics and biosimilar Novartis division, to provide worldwide supply. ” Collaboration Terms and Share Subscription.

article thumbnail

Three Ways to Accelerate Your Clinical Trials

PPD

In todays clinical research landscape, it is both essential and challenging to accelerate clinical trials. Sponsors who embrace an integrated solution gain a strategic advantage by accelerating trials without compromising quality or control, ensuring their therapies reach patients faster and more efficiently.